http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0224181-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f93dbf2d37fdae442e58814555f4cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07ba5e7ff356b7eda43fdfc20eef4b0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00
filingDate 2001-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c133ac35e72f60d728aac79b69d7a183
publicationDate 2003-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0224181-A3
titleOfInvention The use of melatonin for induction of general anesthesia
abstract Melatonin (N-acetyl-5-methoxtryptamine), or its biologically active analogues, are used to induce anesthesia.
priorityDate 2000-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0513702-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0867181-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128

Total number of triples: 19.